telmisartan has been researched along with Migraine Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebina, J; Hanashiro, S; Hirayama, T; Ikeda, K; Ishikawa, Y; Iwasaki, Y; Kano, O; Kawabe, K; Kyuzen, M; Miura, K; Morioka, H; Nagasawa, J; Sawada, M; Takazawa, T; Yanagihashi, M | 1 |
| Davidai, G; Diener, HC; Evers, S; Feuersenger, A; Gendolla, A; Schumacher, H; Straube, A | 1 |
1 trial(s) available for telmisartan and Migraine Disorders
| Article | Year |
|---|---|
Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Telmisartan; Young Adult | 2009 |
1 other study(ies) available for telmisartan and Migraine Disorders
| Article | Year |
|---|---|
Treatment with telmisartan, a long-acting angiotensin II receptor blocker, prevents migraine attacks in Japanese non-responders to lomerizine.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Calcium Channel Blockers; Female; Humans; Japan; Male; Middle Aged; Migraine Disorders; Piperazines; Severity of Illness Index; Telmisartan | 2017 |